SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KELLIS who wrote (107)4/24/1997 7:28:00 AM
From: Hedge   of 998
 
I think that the stock is down due to a weak Bio-tech sector. Most notable is Autoimmune and Amgen has showed weakness. The more I think about this stock the more worried I get. My biggest concern is the pooled data offered to the commitee not the new data that was requested. Second, CEPH bought the November calls and they bought those for a reason. I think either there is more good news
on the way or they are hedging them selves and believe that the FDA will overide a negitive opinion from the 5-8 meeting. Overall I still think
that the existing information and public outcry will force approval on 5-8. Buy the May 20 calls.

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News